Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients

Influenza and other Respiratory Viruses

Volumn 4, Issue 4, 2010, Pages 199-204

  Couturier, Brianne A ^a   Bender, Jeffrey M ^a,b   Schwarz, Monica A ^a   Pavia, Andrew T ^b   Hanson, Kimberly E ^a,b   She, Rosemary C ^a,b  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Hematopoietic stem cell transplant; Pyrosequencing; Surveillance

Indexed keywords

OSELTAMIVIR; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANTIVIRAL RESISTANCE; ARTICLE; CHILD; DISEASE SURVEILLANCE; DRUG DOSE REDUCTION; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INFANT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; VIRUS MUTANT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MUTATION; NEURAMINIDASE; OSELTAMIVIR; YOUNG ADULT;

EID: 77954477452     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2010.00144.x     Document Type: Article

References (15)

1. Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May. 2009. MMWR Morb Mortal Wkly Rep 2010, 58:1436-1440.
2. Uyeki T. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Engl J Med 2009, 361:e110.
3. Dharan NJ, Gubareva LV, Meyer JJ. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009, 301:1034-1041.
4. Hurt AC, Holien JK, Parker MW, Barr IG. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs 2009, 69:2523-2531.
5. Update: Influenza Activity - United States, August 30, 2009-January 9, 2010. MMWR Morb Mortal Wkly Rep 2010, 59:38-43.
6. Influenza A(H1N1) NA-H274 detailed pyrosequencing protocol for antiviral susceptibility testing. http://www.who.int/csr/resources/publications/swineflu/NA_DetailedPyrosequencing_20090513.pdf, 2009 May 13, 2009 [cited 2009 December]; Available at: (Accessed 25 November 2009)
7. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:969-972.
8. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:893-896.
9. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 2009, 361:2296-2297.
10. Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 2010, 362:86-87.
11. Chen H, Cheung CL, Tai H. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis 2009, 15:1970-1972.
12. WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and other Influenza Viruses. Part I: Recommendations: World Health Organization 2010
13. Kumar D, Morris MI, Kotton CN. Guidance on Novel Influenza A/H1N1 in Solid Organ Transplant Recipients. Am J Transplant 2010, 10:18-25.
14. Gaur AH, Bagga B, Barman S. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med 2010, 362:88-89.
15. Deyde VM, Sheu TG, Trujillo AA. Detection of molecular markers of drug resistance in the 2009 pandemic influenza A (H1N1) viruses using pyrosequencing. Antimicrob Agents Chemother 2010, 54:1102-1110. AAC.01417-09